Time Still Matters: Why Canadians with Pulmonary Arterial Hypertension Can’t Wait for Sotatercept

This PH Awareness Month, we’re raising our voices to say it again — Time Still Matters. In this powerful video, Joan Paulin, Board Chair of PHA Canada, and Dr. Sanjay Mehta, Founding Board Member and leading PH expert, discuss the urgency of public access to sotatercept, a groundbreaking new therapy for people living with pulmonary arterial hypertension (PAH). Sotatercept has been approved by Health Canada—but Canadians are still waiting. Every month of delay means patients continue to live under pressure, without access to a treatment that could change their lives. Learn why time is critical, what makes sotatercept so transformative, and how you can take action today to help make this life-saving therapy accessible to all Canadians who need it. 💜 Take action now → www.phacanada.ca/letter 📣 Learn more about PH Awareness Month → www.phacanada.ca/phawarenessmonth #TimeMattersPAH #HeartUnderPressure #PHAwarenessMonth #Sotatercept #PulmonaryHypertension #PHACanada